ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 733981 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 733981; 2) Community: the network communities that were significantly associated with the response to NSC 733981; 3) Molecule: the relationships between components within communities and NSC 733981; 4) MDR: the compounds that were significantly associated with the NSC 733981.

NSC Compound Enrichment Correlation
NSC 305799 2,4-Quinazolinediamine, 6-[[4-(dimethylamino)phenyl]thio]- 0.0072542482863368 0.46779245
NSC 697194 Decanediamide, N,N'-bis[2-(2-hydroxy-1-naphthalenyl)- 5-(3,4-dimethoxyphenyl)methylene]-4-oxo- 3-thiazolidinyl]- 0.0072542482863368 0.53015565
NSC 703764 Null 0.0072542482863368 0.35653873
NSC 757113 METHOTREXATE(+/-) 0.00725424828633685 0.57790302
NSC 9706 Triethylenemelamine 0.00725424828633685 0.59957261
NSC 674498 Null 0.0095730951125627 0.19837221
NSC 708070 Gemcitabinemonophosphate 10 0.0095730951125627 0.62234297
NSC 744622 4,8,13,17,21-Pentamethyl-docosa-4,8,12,16,20-pentaenoic acid[1-(3,3-difluoro-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-2-oxo-1,2-dihydro-pyrimidin-4-yl]-amide 0.00957309511256283 0.44074061
NSC 132313 Dianhydrogalactitol 0.0105244982742819 0.56208272
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0105244982742819 0.40790849
Total:39  Current:7    [First] [Prev] [Next] [Last]